Total Payments
$157,639
2024 Payments
$724.22
Companies
20
Transactions
676

Payment Breakdown by Category

Other$121,955 (77.4%)
Travel$13,225 (8.4%)
Food & Beverage$13,004 (8.2%)
Consulting$9,400 (6.0%)
Education$55.50 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $121,955 61 77.4%
Travel and Lodging $13,225 69 8.4%
Food and Beverage $13,004 533 8.2%
Consulting Fee $9,400 5 6.0%
Education $55.50 8 0.0%

Top Paying Companies

Company Total Records Latest Year
Supernus Pharmaceuticals, Inc. $77,462 311 $0 (2023)
Ironshore Pharmaceuticals Inc. $51,919 92 $0 (2023)
UCB, Inc. $16,855 93 $0 (2024)
Neos Therapeutics, LP $7,169 14 $0 (2017)
Eisai Inc. $1,133 40 $0 (2021)
LivaNova USA, Inc. $881.33 20 $0 (2021)
Neurelis, Inc. $449.42 17 $0 (2023)
Shire North American Group Inc $384.70 30 $0 (2019)
Lundbeck LLC $325.32 9 $0 (2018)
Corium, LLC $285.48 13 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $724.22 5 UCB, Inc. ($724.22)
2023 $3,374 24 UCB, Inc. ($2,994)
2022 $17,117 66 Supernus Pharmaceuticals, Inc. ($13,887)
2021 $20,975 89 Supernus Pharmaceuticals, Inc. ($14,937)
2020 $16,320 55 Ironshore Pharmaceuticals Inc. ($10,143)
2019 $41,528 155 Ironshore Pharmaceuticals Inc. ($39,914)
2018 $19,638 137 Supernus Pharmaceuticals, Inc. ($18,470)
2017 $37,964 145 Supernus Pharmaceuticals, Inc. ($29,577)

All Payment Transactions

676 individual payment records from CMS Open Payments — Page 1 of 28

Date Company Product Nature Form Amount Type
09/17/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $115.48 General
Category: Neurology
04/23/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $128.17 General
Category: Neurology
04/19/2024 UCB, Inc. Briviact (Drug) Consulting Fee Cash or cash equivalent $350.00 General
Category: Neurology
01/30/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $65.00 General
Category: Neurology
01/23/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $65.57 General
Category: Neurology
11/20/2023 UCB, Inc. Nayzilam (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,980.00 General
Category: Neurology
11/16/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $10.77 General
Category: CNS Stimulant for ADHD
11/16/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $5.13 General
Category: CNS Stimulant for ADHD
11/08/2023 UCB, Inc. Nayzilam (Drug) Food and Beverage In-kind items and services $118.68 General
Category: Neurology
10/31/2023 UCB, Inc. Nayzilam (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $825.00 General
Category: Neurology
08/10/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $17.01 General
Category: CNS Stimulant for ADHD
08/05/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $17.63 General
Category: Neurology
06/15/2023 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $26.94 General
Category: EPILEPSY
06/08/2023 Catalyst Pharmaceuticals, Inc. FYCOMPA (Drug) Food and Beverage Cash or cash equivalent $15.82 General
Category: NEUROLOGY
06/01/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $16.35 General
Category: CNS Stimulant for ADHD
05/11/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $7.32 General
Category: Neurology
04/27/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $13.02 General
Category: Neurology
04/13/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $6.24 General
Category: Neurology
04/11/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $112.15 General
Category: CNS Stimulant for ADHD
04/06/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $18.35 General
Category: CNS Stimulant for ADHD
03/23/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $2.63 General
Category: CNS Stimulant for ADHD
03/21/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $13.78 General
Category: PSYCHOLOGY
03/10/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $14.11 General
Category: Neurology
02/23/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $12.27 General
Category: Neurology
02/16/2023 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $23.58 General
Category: EPILEPSY

About Dr. Michael Hammer, MD

Dr. Michael Hammer, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Saint Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508808759.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hammer, MD has received a total of $157,639 in payments from pharmaceutical and medical device companies, with $724.22 received in 2024. These payments were reported across 676 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($121,955).

Practice Information

  • Specialty Neurology with Special Qualifications in Child Neurology
  • Other Specialties Neurology with Special Qualifications in Child Neurology, Neurology with Special Qualifications in Child Neurology
  • Location Saint Petersburg, FL
  • Active Since 06/12/2006
  • Last Updated 04/10/2024
  • Taxonomy Code 2084N0402X
  • Entity Type Individual
  • NPI Number 1508808759

Products in Payments

  • Jornay PM 20mg capsules (Bottle of 100) (Drug) $39,914
  • QELBREE (Drug) $28,757
  • OXTELLAR XR (Drug) $26,841
  • TROKENDI XR (Drug) $21,827
  • JORNAY PM (Drug) $12,005
  • Adzenys XR-ODT (Drug) $7,169
  • Briviact (Drug) $5,552
  • Nayzilam (Drug) $4,429
  • Fycompa (Drug) $1,133
  • VNS Therapy (Device) $980.95
  • VYVANSE (Drug) $577.70
  • VALTOCO (Drug) $449.42
  • Vimpat (Drug) $404.75
  • Fintepla (Drug) $374.22
  • ONFI (Drug) $325.32
  • Azstarys (Drug) $199.13
  • Epidiolex (Drug) $141.07
  • AZSTARYS (Drug) $86.35
  • APTIOM (Drug) $70.17
  • MYDAYIS (Drug) $47.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology with Special Qualifications in Child Neurology Doctors in Saint Petersburg